Current directions of biologic therapies in inflammatory bowel disease.
about
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementProgress in the diagnosis and treatment of inflammatory bowel disease.Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patientsRegional and mucosal memory T cells.Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's disease.Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.
P2860
Q26777627-BCC41167-8ABD-4B9E-9D1F-FB5A19B82835Q34699653-A91CC26D-3527-40E3-8694-50D4C843939EQ36238054-0B9CFBEA-2CC6-47D0-9F8C-22A89D27EA08Q37899121-459199B3-0320-4E5A-BA40-73882352143DQ38894023-093CA0AB-4212-4C1A-AD26-870777ED380AQ39420665-0D3ECCB4-F487-446B-8565-4EAA18D39FA1Q39556021-377936E4-3D68-40CA-9DB6-5FCA8E16CD87Q43474062-8ABEBB2A-473D-4227-BE1C-3CD817ADDC5BQ49534303-C0349839-A575-476A-86E1-9AF15AE8696EQ51165811-DA1C36CF-601C-45B1-B57E-68AB485D7376
P2860
Current directions of biologic therapies in inflammatory bowel disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Current directions of biologic therapies in inflammatory bowel disease.
@en
type
label
Current directions of biologic therapies in inflammatory bowel disease.
@en
prefLabel
Current directions of biologic therapies in inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
Current directions of biologic therapies in inflammatory bowel disease.
@en
P2093
Catherine Reenaers
Edouard Louis
Jacques Belaiche
P2860
P304
P356
10.1177/1756283X09356872
P577
2010-03-01T00:00:00Z